Affimed NV (AFMD)
5.31
-0.13
(-2.39%)
USD |
NASDAQ |
May 17, 16:00
5.31
0.00 (0.00%)
After-Hours: 20:00
Affimed Net Income (Quarterly): -21.76M for Dec. 31, 2023
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -21.76M |
| September 30, 2023 | -26.52M |
| June 30, 2023 | -32.05M |
| March 31, 2023 | -34.35M |
| December 31, 2022 | -34.19M |
| September 30, 2022 | -16.61M |
| June 30, 2022 | -20.67M |
| March 31, 2022 | -18.70M |
| December 31, 2021 | -26.41M |
| September 30, 2021 | -20.16M |
| June 30, 2021 | -22.60M |
| March 31, 2021 | 1.702M |
| December 31, 2020 | -17.73M |
| September 30, 2020 | -6.977M |
| June 30, 2020 | -13.48M |
| March 31, 2020 | -9.147M |
| December 31, 2019 | -14.39M |
| September 30, 2019 | -12.10M |
| June 30, 2019 | -11.62M |
| March 31, 2019 | 2.104M |
| December 31, 2018 | 9.995M |
| September 30, 2018 | -13.98M |
| Date | Value |
|---|---|
| June 30, 2018 | -9.569M |
| March 31, 2018 | -10.08M |
| December 31, 2017 | -7.561M |
| September 30, 2017 | -9.523M |
| June 30, 2017 | -8.744M |
| March 31, 2017 | -8.261M |
| December 31, 2016 | -5.849M |
| September 30, 2016 | -11.49M |
| June 30, 2016 | -9.08M |
| March 31, 2016 | -9.335M |
| December 31, 2015 | -6.87M |
| September 30, 2015 | -8.104M |
| June 30, 2015 | -5.729M |
| March 31, 2015 | -1.674M |
| December 31, 2014 | -6.619M |
| September 30, 2014 | 9.718M |
| June 30, 2014 | 18.32M |
| March 31, 2014 | -21.44M |
| December 31, 2013 | -3.471M |
| September 30, 2013 | -15.31M |
| June 30, 2013 | -10.91M |
| March 31, 2013 | -4.813M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-34.35M
Minimum
Mar 2023
1.702M
Maximum
Mar 2021
-18.83M
Average
-18.70M
Median
Mar 2022
Net Income (Quarterly) Benchmarks
| InflaRx NV | -10.49M |
| MorphoSys AG | 51.98M |
| BioNTech SE | -342.26M |
| Immatics NV | -3.317M |
| CureVac NV | -93.32M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 0.4448M |
| Total Expenses (Quarterly) | 26.50M |
| EPS Diluted (Quarterly) | -1.497 |
| Enterprise Value | 12.80M |
| Profit Margin (Quarterly) | -4.89K% |
| Earnings Yield | -146.2% |
| Normalized Earnings Yield | -148.33 |